Investing.com - GW Pharma (NASDAQ:GWPH) ADR reported on Tuesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
GW Pharma ADR announced earnings per share of $-0.03 on revenue of $137.1M. Analysts polled by Investing.com anticipated EPS of $-0.05 on revenue of $127.38M.
GW Pharma ADR shares are down 14.6% from the beginning of the year, still down 37.04% from its 52 week high of $141.83 set on July 21. They are under-performing the Nasdaq which is up 22.12% from the start of the year.
GW Pharma ADR shares gained 6.39% in pre-market trade following the report.
GW Pharma ADR follows other major Healthcare sector earnings this month
GW Pharma ADR's report follows an earnings beat by J&J on October 13, who reported EPS of $2.2 on revenue of $21.08B, compared to forecasts EPS of $1.98 on revenue of $20.2B.
Pfizer had beat expectations on October 27 with third quarter EPS of $0.72 on revenue of $12.13B, compared to forecast for EPS of $0.71 on revenue of $12.31B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar